Status epilepticus
Dinesh Raj1, Sheffali Gulati, Rakesh Lodha
1Department of Pediatrics, AIIMS, Ansari Nagar, New Delhi, 110029, India.
Insights
Status epilepticus (SE) is a critical pediatric neurological emergency. Prompt pharmacotherapy, starting with benzodiazepines, is crucial for seizure termination and improving outcomes in children.
Area of Science:
- Neurology
- Pediatrics
- Emergency Medicine
Background:
- Status epilepticus (SE) is a frequent and serious neurological emergency in children, linked to substantial morbidity and mortality.
- The definition of SE has evolved, with operational definitions now emphasizing durations as short as 5 minutes.
Purpose of the Study:
- To outline the management principles for pediatric status epilepticus.
- To detail pharmacotherapeutic strategies for terminating seizures in SE.
- To highlight the importance of simultaneous diagnosis and seizure control.
Main Methods:
- Review of current management guidelines for status epilepticus.
- Discussion of first-line, second-line, and third-line pharmacotherapies.
- Emphasis on alternative administration routes for medications in pediatric patients.
Main Results:
- Benzodiazepines (lorazepam, diazepam, midazolam) are the first-line treatment for SE.
- Alternative routes like buccal or rectal administration are available for children without IV access.
- Second-line agents include phenytoin, with valproate, phenobarbitone, or levetiracetam for persistent seizures.
- Refractory SE may require midazolam infusion or agents like thiopentone or propofol.
Conclusions:
- Timely and effective pharmacotherapy is essential for managing pediatric status epilepticus.
- Prolonged SE increases the risk of long-term neurological sequelae, including epilepsy and cognitive deficits.
- Integrated management focusing on seizure termination and underlying cause evaluation improves patient outcomes.
Abstract:
Status epilepticus is a common neurological emergency in childhood and associated with significant morbidity and mortality. Status epilepticus (SE) has been defined as continuous seizure activity lasting more than 30 min or 2 or more seizures in this duration without gaining consciousness between them. However, the operational definition has brought the time down to 5 min. Management can be broadly divided into initial stabilization, seizure termination, and evaluation and treatment of the underlying cause. Diagnostic evaluation and seizure control should be achieved simultaneously to improve outcome. Seizure termination is achieved by pharmacotherapy. Benzodiazepines are the first line drugs for SE. Commonly used drugs include lorazepam, diazepam, and midazolam. In children without an IV access, buccal or nasal midazolam or rectal diazepam can be used. Phenytoin as a second line agent is usually indicated when seizure is not controlled after one or more doses of benzodiazepines. If the seizures continue to persist, valproate, phenobarbitone or levetiracetam is indicated. Midazolam infusion is useful in refractory status epilepticus. Thiopentone, propofol or high dose phenobarbitone are considered for treatment of refractory status epilepticus. Prolonged SE is associated with higher morbidity and mortality. Long term neurological sequelae include epilepsy, behavioural problems, cognitive decline, and focal neurologic deficits.
More Related Videos
Related Concept Videos
Seizures l: Introduction
Epilepsy ll: Types
Seizures: Classification
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Seizures ll: Types
Electroconvulsive Therapy


